NCT06978361 Comparison of Efficacy of Microneedling With Platelet Rich Plasma Vs Microneedling With Topical Insulin in the Treatment of Acne Scars
| NCT ID | NCT06978361 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Khyber Teaching Hospital |
| Condition | Post-acne Atrophic Scars |
| Study Type | INTERVENTIONAL |
| Enrollment | 116 participants |
| Start Date | 2025-03-01 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 116 participants in total. It began in 2025-03-01 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study compares the outcome of two procedures for the treatment of atrophic acne scars.
Eligibility Criteria
Inclusion Criteria: Patients confirmed with post-acne atrophic scars . No prior treatment for scars in last 6 months. \- Exclusion Criteria: * Patient with active acne or other skin conditions (e.g eczema , psoriasis). Patients on oral or topical retinoids. Pregnant or lactating Mothers. Patients with recurrent herpes simplex infection. Previous Hx of keloids / hypertrophic scarring. Deranged blood glucose levels. Bleeding disorders
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06978361 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 50 Years, studying Post-acne Atrophic Scars. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06978361 currently recruiting?
Yes, NCT06978361 is actively recruiting participants. Contact the research team at soaiba91@gmail.com for enrollment information.
Where is the NCT06978361 trial being conducted?
This trial is being conducted at Peshawar, Pakistan.
Who is sponsoring the NCT06978361 clinical trial?
NCT06978361 is sponsored by Khyber Teaching Hospital. The trial plans to enroll 116 participants.